Imatinib, marketed as Glivec in Europe and Gleevec in the US, has been used to treat myeloid leukaemia (CML) and gastrointestinal stromal tumor (GIST) since 2001.
英
美
- 伊马替尼,推销作为格列卫在欧洲和伊马替尼在美国,已被用来治疗骨髓性白血病(慢性骨髓性白血病)和胃肠道间质肿瘤( gist )的,自2001年以来。